Joren Stroobants

This study develops a biosafety level 2-compatible panel of orthoebolaviruses for screening broad-spectrum antivirals, identifying both broad-acting and virus-specific candidates.

This paper develops optimized RNA polymerase II-driven minigenomes for Nipah virus to enable safer research and antiviral screening.

Flavitransin inhibits dengue virus polyprotein insertion into the ER membrane, showing broad antiviral activity against flaviviruses.

This study identifies mutations in influenza hemagglutinin that increase acid-stability and decrease cleavability, with implications for viral transmissibility and vaccine development.